Floatz logo

Umbilical Cord Blood Mononuclear Cells

Leukemia or MDS in Aplasia

Masonic Cancer Center, University of MinnesotaCell therapyPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

137 Active assets in the Leukemia or MDS in Aplasia cohort.

Asset / SponsorPhaseRating
Inno-206
OHSU Knight Cancer Institute
Phase 4BBB
Cyclophosphamide
National Cancer Institute (NCI)
Phase 3BBB
DEXAMETHASONE
City of Hope Medical Center
Phase 3BB
Teclistamab
Janssen Pharmaceutical K.K.
Phase 2BB
ALLOGENEIC, EX VIVO EXPANDED, UMBILICAL CORD BLOOD-DERIVED HEMATOPOIETIC CD133+ PROGENITOR CELLS- CULTURED FRACTION (CF)
Gamida Cell ltd
Phase 3BB

View all 50 →

Same molecule, other indications

Umbilical Cord Blood Mononuclear Cells is also rated in:

Burkitt lymphomaDormant
B
Indicative ·
57 / 100
View asset →
acute lymphoblastic leukemiaDormant
B
Indicative ·
57 / 100
View asset →
T-cell and NK-cell neoplasmDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →